tiprankstipranks
Trending News
More News >
Century Sage Scientific Holdings Ltd (HK:1450)
:1450
Hong Kong Market
Advertisement

Century Sage Scientific Holdings Ltd (1450) AI Stock Analysis

Compare
0 Followers

Top Page

HK:1450

Century Sage Scientific Holdings Ltd

(1450)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 4o)
Rating:59Neutral
Price Target:
HK$1.00
▼(-0.99% Downside)
The overall stock score of 59 reflects a company with strong revenue growth and a solid balance sheet but facing challenges in profitability and cash flow generation. Technical indicators suggest mixed momentum, and the valuation is moderate. The absence of earnings call insights and corporate events limits additional context.

Century Sage Scientific Holdings Ltd (1450) vs. iShares MSCI Hong Kong ETF (EWH)

Century Sage Scientific Holdings Ltd Business Overview & Revenue Model

Company DescriptionBe Friends Holding Ltd. is an investment company, which engages in the provision of hardware and software all-media application solutions. It operates through the following business segments: New Media Services, Application Solutions, System Maintenance Services, and Sales of Self-Developed Products. The company was founded by Chi Sum Lo in 2007 and is headquartered in Hangzhou, China.
How the Company Makes MoneyCentury Sage Scientific Holdings Ltd generates revenue primarily through the sale and implementation of its video solutions and services. Key revenue streams include the provision of broadcast and transmission solutions, which involve designing, building, and maintaining systems for television and media companies. Additionally, the company earns money by offering sports event broadcasting services, which include live broadcasting and production services for sports events. System maintenance services also contribute to its earnings by providing ongoing support and maintenance for the technology and systems it implements. Significant partnerships with media companies, sports organizations, and technology providers enhance its service offerings and contribute to its revenue.

Century Sage Scientific Holdings Ltd Financial Statement Overview

Summary
The company shows strong revenue growth and a solid balance sheet, indicating potential for long-term stability. However, the decline in net profit margin and cash flow generation pose risks to financial health, necessitating a focus on operational efficiency and liquidity management.
Income Statement
65
Positive
The income statement reflects a strong revenue growth trajectory, with total revenue increasing significantly from 2023 to 2024. Gross profit margin is solid at 47.9%, indicating efficient cost management. However, the net profit margin has decreased to 6.5% from 11.1% in the previous year, suggesting higher expenses or lower operational efficiency. The EBIT margin is moderate at 8.5%, showing some profitability challenges.
Balance Sheet
70
Positive
The balance sheet shows a healthy equity ratio of 45.3%, indicating a stable capital structure. The debt-to-equity ratio is moderate at 0.60, reflecting manageable leverage levels. Return on equity is strong at 19.5%, demonstrating efficient use of equity capital. Overall, the balance sheet presents a balanced financial position with no significant red flags.
Cash Flow
50
Neutral
The cash flow statement reveals challenges with cash generation, as operating and free cash flows are zero for 2024. This could indicate issues with liquidity or reinvestment capacity. The lack of free cash flow growth and operating cash flow to net income ratio suggest potential cash management issues despite previous years showing positive cash flows.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.25B1.07B425.61M202.79M153.31M
Gross Profit599.30M566.91M189.80M60.33M55.85M
EBITDA119.87M184.30M19.76M-22.52M-44.96M
Net Income81.71M119.46M-9.21M-61.62M-97.53M
Balance Sheet
Total Assets923.92M754.59M446.91M422.68M498.64M
Cash, Cash Equivalents and Short-Term Investments113.32M149.54M50.93M60.06M12.78M
Total Debt252.83M168.96M151.23M182.62M182.12M
Total Liabilities510.21M452.88M343.92M334.29M392.86M
Stockholders Equity418.99M297.51M93.30M65.80M80.88M
Cash Flow
Free Cash Flow-45.69M167.14M-6.90M7.43M-2.52M
Operating Cash Flow-27.58M182.99M-2.08M7.81M-1.61M
Investing Cash Flow-58.44M-74.47M32.34M4.28M-3.18M
Financing Cash Flow52.47M-10.28M-34.83M36.10M5.00M

Century Sage Scientific Holdings Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1.01
Price Trends
50DMA
1.04
Negative
100DMA
1.00
Positive
200DMA
0.97
Positive
Market Momentum
MACD
>-0.01
Negative
RSI
50.19
Neutral
STOCH
20.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1450, the sentiment is Positive. The current price of 1.01 is above the 20-day moving average (MA) of 0.99, below the 50-day MA of 1.04, and above the 200-day MA of 0.97, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 50.19 is Neutral, neither overbought nor oversold. The STOCH value of 20.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1450.

Century Sage Scientific Holdings Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
10.37B23.828.15%2.28%-17.90%56.67%
65
Neutral
2.74B32.440.00%12.46%0.00%
62
Neutral
734.66M6.8619.71%421.56%328.43%
59
Neutral
HK$1.40B24.1611.90%-1.52%-67.16%
56
Neutral
5.71B-62.14-17.45%3.97%-211.11%
47
Neutral
3.17B-41.50-45.62%-16.86%-7.51%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1450
Century Sage Scientific Holdings Ltd
1.01
-0.29
-22.31%
CHNVF
China Youzan
0.02
0.01
100.00%
DE:51N
AsiaInfo Technologies Limited
1.17
0.62
112.73%
HK:1808
Enterprise Development Holdings Limited
3.00
-0.80
-21.05%
HK:1588
Chanjet Information Technology Co., Ltd. Class H
8.57
5.06
144.16%
HK:1782
Vixtel Technologies Holdings Ltd.
4.09
1.09
36.33%

Century Sage Scientific Holdings Ltd Corporate Events

Be Friends Holding Limited Delays Circular Dispatch for Acquisition
Sep 12, 2025

Be Friends Holding Limited has announced a delay in the dispatch of a circular related to its acquisition of the entire equity interests in a target company. The circular, which includes details on the acquisition terms and recommendations from the Independent Board Committee, was initially expected to be sent to shareholders by September 12, 2025. However, the dispatch has been postponed to on or before September 30, 2025, due to the need for additional time to finalize certain information.

The most recent analyst rating on (HK:1450) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Century Sage Scientific Holdings Ltd stock, see the HK:1450 Stock Forecast page.

Be Friends Holding Limited Reports 2025 Interim Results Amid Industry Challenges
Aug 27, 2025

Be Friends Holding Limited, operating in the live-streaming e-commerce industry, reported its interim results for the first half of 2025. The company experienced a 9.8% increase in operating revenue, reaching approximately RMB0.62 billion, attributed to the expansion of its live-streaming channels and multi-platform strategies. However, net profit declined by 37.4% due to increased costs in platform traffic acquisition and investments in the “Friends Cloud” intelligent system. The company is focusing on technology-driven strategies and operational efficiency to navigate industry challenges and foster resilience.

The most recent analyst rating on (HK:1450) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Century Sage Scientific Holdings Ltd stock, see the HK:1450 Stock Forecast page.

Be Friends Holding Limited Announces Strategic Acquisition
Aug 22, 2025

Be Friends Holding Limited has announced a transaction involving the acquisition of the entire equity interests in a target company. The valuation of the target company was conducted using the discounted cash flow (DCF) method, which was deemed more appropriate than asset-based or market approaches due to the target’s growth stage and profitability. This acquisition is expected to enhance Be Friends Holding Limited’s market positioning in the education services sector, as the target company has demonstrated sustained profitability and aligns with the company’s strategic growth plans.

The most recent analyst rating on (HK:1450) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Century Sage Scientific Holdings Ltd stock, see the HK:1450 Stock Forecast page.

Be Friends Holding Limited Provides Supplemental Information on 2024 Annual Report
Aug 15, 2025

Be Friends Holding Limited has announced supplemental information regarding its 2024 Annual Report. The company, which operates with its subsidiaries, is focused on utilizing its 2,550,000 treasury shares in accordance with the Listing Rules, potentially through sale or transfer, based on market conditions and capital management needs. This update does not alter any other information in the Annual Report.

Be Friends Holding Limited Announces Upcoming Board Meeting
Aug 13, 2025

Be Friends Holding Limited, a company incorporated in the Cayman Islands, has announced a board meeting scheduled for August 27, 2025. The meeting will address the approval and publication of the interim results for the first half of 2025 and consider the payment of an interim dividend, if applicable.

Century Sage Scientific Expands with Strategic Acquisition
Aug 5, 2025

Century Sage Scientific Holdings Ltd has announced a significant acquisition, where its subsidiary will acquire 100% equity interests in a target company for RMB180.0 million. This acquisition will make the target company an indirect wholly-owned subsidiary, integrating its financial results into Century Sage’s consolidated statements. The transaction is classified as both a disclosable and connected transaction under Hong Kong’s Listing Rules, necessitating shareholder approval and an independent board review. The move is expected to enhance the company’s market positioning and operational capabilities.

Be Friends Holding Limited Reports Growth in Q2 2025 GMV
Jul 10, 2025

In the second quarter of 2025, Be Friends Holding Limited reported a Gross Merchandise Volume (GMV) of approximately RMB3.78 billion, marking a 7.08% increase compared to the same period in 2024. The cumulative GMV for the first half of 2025 reached approximately RMB6.98 billion, reflecting a 17.11% rise over the first half of 2024. This growth highlights the company’s expanding influence in the all-media service sector, although the data is preliminary and unaudited, urging stakeholders to exercise caution.

Be Friends Holding Limited Announces Executive Director Resignation
Jun 19, 2025

Be Friends Holding Limited, a company incorporated in the Cayman Islands, announced the resignation of Mr. Lo Chi Sum as an executive director, effective from June 19, 2025. Mr. Lo will continue his role as the CEO of Vision Technology, a subsidiary of the company. The resignation is attributed to Mr. Lo’s desire to focus on other business commitments and personal affairs. The board expressed gratitude for Mr. Lo’s contributions during his tenure.

Century Sage Scientific Holdings Ltd Announces Board Roles and Functions
Jun 19, 2025

Century Sage Scientific Holdings Ltd has announced the roles and functions of its board members. The board comprises executive directors including Mr. Li Jun as Chairman and Mr. Li Liang as CEO, along with independent non-executive directors. This announcement provides clarity on the governance structure and committee memberships, potentially impacting the company’s strategic decision-making and stakeholder relations.

Be Friends Holding Limited Successfully Passes All AGM Resolutions
Jun 16, 2025

Be Friends Holding Limited, a company incorporated in the Cayman Islands, announced that all resolutions proposed at its Annual General Meeting held on June 16, 2025, were passed. The resolutions included the re-election of executive directors, authorization for the board to set directors’ remuneration, re-appointment of auditors, and granting of general mandates for share repurchase and issuance. This successful AGM indicates strong shareholder support and positions the company for continued governance and operational stability.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 13, 2025